Drug Database
Back to search

France· FR:67966754

ICAZ LP 2,5 mg, gélule à libération prolongée

A isradipine product containing isradipine, registered in France by FARMACEUTICO SIT, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C08CA03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedICAZ LP 2,5 mg, gélule à libération p…ATCC08CA03REGISTER NO.FR:67966754PACKS LISTED3CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about isradipineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Isradipine is registered in 5 of 19 countries.

Countries holding a registration under ATC C08CA03 (isradipine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 4 of them publish a price we can compare per daily dose
Search isradipine products by name

Isradipine · ATC C08CA03

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of isradipine costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Isradipine · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • US United States$1.99 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ISRADIPINE
Manufacturer
FARMACEUTICO SIT
Country
France (FR)
ATC code
C08CA03
ATC class
Isradipine
Defined daily dose
5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 3

3 priced
  • cip13
    3400933340780
    plaquette(s) PVC-Aluminium de 30 gélule(s)
    EUR 11.05
  • cip13
    3400933341091
    film(s) thermosoudé(s) polyamide aluminium PVC-Aluminium de 30 gélule(s)
    EUR 11.05
  • cip13
    3400937393782
    plaquette(s) PVC-Aluminium de 90 comprimé(s)
    EUR 31.32

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

283 interactions on record for isradipine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check isradipine against other medicinesHow interaction checks work

Isradipine · interactions on record

283 records

  • 8 severe
  • 171 moderate
  • 2 minor
  • 55 info

Most severe, free to view

  • DolasetronA04AA04severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • MitotaneL01XX23severe

47 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Isradipine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All isradipine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f31301af-d9ef-471f-8283-c275690d0ac1
GET /v1/drugs/f31301af-d9ef-471f-8283-c275690d0ac1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67966754",
  "date_amm": "1990-12-31",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ISRADIPINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about isradipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console